Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)

Kidney International

Volumn 77, Issue 11, 2012, Pages 1020-1030

  Endre, Zoltán H ^a   Walker, Robert J ^b   Pickering, John W ^a   Shaw, Geoffrey M ^a,c   Frampton, Christopher M ^a   Henderson, Seton J ^a,c   Hutchison, Robyn ^b   Mehrtens, Jan E ^a,c   Robinson, Jillian M ^a   Schollum, John B W ^b,f   Westhuyzen, Justin ^a   Celi, Leo A ^b   McGinley, Robert J ^d   Campbell, Isaac J ^a   George, Peter M ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d DEAKIN UNIVERSITY   (Australia)

^e CANTERBURY HEALTH LABORATORIES   (New Zealand)

^f DUNEDIN HOSPITAL   (New Zealand)

Author keywords

acute renal failure; clinical trial; erythropoietin; randomized controlled trials

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; ERYTHROPOIETIN; GAMMA GLUTAMYLTRANSFERASE; PLACEBO; ANTIANEMIC AGENT; BIOLOGICAL MARKER;

ACIDOSIS; ACUTE KIDNEY FAILURE; ADULT; AGED; ALKALOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; EARLY INTERVENTION; EMERGENCY HEALTH SERVICE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPOALBUMINEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; INTENSIVE CARE UNIT; ISCHEMIA; LIVER DYSFUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEIZURE; SIDE EFFECT; STROKE; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NEW ZEALAND; PATIENT SELECTION; PLACEBO EFFECT; PREDICTION AND FORECASTING; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; URINE;

ACUTE DISEASE; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CREATININE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMATINICS; HUMANS; INTENSIVE CARE UNITS; KIDNEY DISEASES; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT SELECTION; PLACEBO EFFECT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TRIAGE;

EID: 77955915903     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.25     Document Type: Article

References (48)

1. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients-A multinational, multicenter study. JAMA 2005; 294: 813-818. (Pubitemid 41175724)
2. Endre ZH. Acute kidney injury: definitions and new paradigms. Adv Chronic Kidney Dis 2008; 15: 213-221.
3. Bellomo R, Ronco C, Kellum JA et al. for the Acute Dialysis Quality Initiative workgroup: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
4. Mehta RL, Kellum JA, Shah SV et al. for the Acute Kidney Injury Network: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
5. Bagshaw SM, George C, Dinu I et al. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1203-1210. (Pubitemid 351767483)
6. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370. (Pubitemid 46179340)
7. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008; 73: 538-546. (Pubitemid 351264114)
8. Coca SG, Yalavarthy R, Concato J et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008; 73: 1008-1016. (Pubitemid 351543898)
9. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol 2008; 48: 463-493. (Pubitemid 351738161)
10. Bonventre JV. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 2007; 156: 213-219.
11. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008; 36: S159-S165. (Pubitemid 351483046)
12. Westhuyzen J, Endre ZH, Reece G et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003; 18: 543-551. (Pubitemid 36305660)
13. Parikh CR, Abraham E, Ancukiewicz M et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16: 3046-3052. (Pubitemid 44743502)
14. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238. (Pubitemid 40469655)
15. Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008; 73: 465-472. (Pubitemid 351186293)
16. Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest 2008; 68: 78-83. (Pubitemid 351883663)
17. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520. (Pubitemid 43841396)
18. Nemoto T, Yokota N, Keane WF et al. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 2001; 59: 246-251. (Pubitemid 32055232)
19. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124. (Pubitemid 39031350)
20. Johnson DW, Forman C, Vesey DA. Novel renoprotective actions of erythropoietin: new uses for an old hormone. Nephrology (Carlton) 2006; 11: 306-312. (Pubitemid 44086875)
21. Johnson DW, Pat B, Vesey DA et al. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006; 69: 1806-1813. (Pubitemid 43739209)
22. Endre ZH, Ratcliffe PJ, Tange JD et al. Erythrocytes alter the pattern of renal hypoxic injury: predominance of proximal tubular injury with moderate hypoxia. Clin Sci 1989; 76: 19-29. (Pubitemid 19039087)
23. Chew SL, Lins RL, Daelemans R et al. Urinary enzymes in acute renal failure. Nephrol Dial Transplant 1993; 8: 507-511. (Pubitemid 23199484)
24. Rivers BJ, Walter PA, OBrien TD et al. Evaluation of urine gamma-glutamyl transpeptidase-to-creatinine ratio as a diagnostic tool in an experimental model of aminoglycoside-induced acute renal failure in the dog. J Am Anim Hosp Assoc 1996; 32: 323-336. (Pubitemid 126506874)
25. Bonventre JV, Brezis M, Siegel N et al. Acute renal failure. I. Relative importance of proximal vs distal tubular injury. Am J Physiol-Renal 1998; 275: F623-F631.
26. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505. (Pubitemid 36337492)
27. Ehrenreich H, Weissenborn K, Prange H et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009; 40: e647-e656.
28. Pickering JW, Endre ZH. Secondary prevention of acute kidney injury. Curr Opin Crit Care 2009; 15: 488-497.
29. Allgren RL, Marbury TC, Rahman SN et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336: 828-834.
30. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999; 55: 2423-2432. (Pubitemid 29256497)
31. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008; 73: 863-869. (Pubitemid 351398278)
32. Molitoris B, Melnikov V, Okusa M et al. Technology insight: biomarker development in acute kidney injury-what can we anticipate? Nat Clin Pract Nephrol 2008; 4: 154-165. (Pubitemid 351312080)
33. Postorino M, Marino C, Tripepi G et al. Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int 2008; 74: S64-S66.
34. Vaidya VS, Ford GM, Waikar SS et al. A rapid urine test for early detection of kidney injury. Kidney Int 2009; 76: 108-114.
35. Han WK, Wagener G, Zhu Y et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009; 4: 873-882.
36. Parikh C, Mishra J, Ma Q et al. Neutrophil gelatinase-associated lipocalin and interleukin-18: early, sequential, predictive biomarkers of acute kidney injury after cardiac surgery. J Invest Med 2006; 54: S382.
37. Nickolas TL, O0Rourke MJ, Yang J et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810-819. (Pubitemid 351786928)
38. Bellomo R, Bagshaw S, Langenberg C et al. Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol 2007; 156: 1-9.
39. Solomon R, Segal A. Defining acute kidney injury: what is the most appropriate metric? Nat Clin Pract Nephrol 2008; 4: 208-215. (Pubitemid 351451293)
40. Waikar S, Bonventre J. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20: 672-679.
41. Pickering JW, Endre ZH. GFR shot by RIFLE: errors in staging acute kidney injury. Lancet 2009; 373: 1318-1319.
42. Endre ZH, Pickering JW. Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI). Nephrol Dial Transpl 2010; 25: 107-118.
43. Bagshaw SM, George C, Bellomo R. For the ANZICS Database Management Committee: a comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1569-1574. (Pubitemid 351767782)
44. Joannidis M, Metnitz B, Bauer P et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intens Care Med 2009; 35: 1692-1702.
45. Pickering JW, Frampton CM, Endre ZH. Evaluation of trial outcomes in acute kidney injury by creatinine modeling. Clin J Am Soc Nephrol 2009; 4: 1705-1715.
46. Bagshaw SM, Uchino S, Cruz D et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transpl 2009; 24: 2739-2751.
47. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
48. Thakar CV, Arrigain S, Worley S et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16: 162-168. (Pubitemid 43073168)